CA2118522A1 - Administration au moment opportun de glycosides oligosaccharidiques associes a des determinants du groupe sanguin et ayant une structure centrale de type i ou ii afin de reduire l'inflammation chez un mammifere sensibilise par suite de l'exposition a un antigene - Google Patents
Administration au moment opportun de glycosides oligosaccharidiques associes a des determinants du groupe sanguin et ayant une structure centrale de type i ou ii afin de reduire l'inflammation chez un mammifere sensibilise par suite de l'exposition a un antigeneInfo
- Publication number
- CA2118522A1 CA2118522A1 CA002118522A CA2118522A CA2118522A1 CA 2118522 A1 CA2118522 A1 CA 2118522A1 CA 002118522 A CA002118522 A CA 002118522A CA 2118522 A CA2118522 A CA 2118522A CA 2118522 A1 CA2118522 A1 CA 2118522A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- compound
- hydrogen
- carbon atoms
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88901792A | 1992-05-26 | 1992-05-26 | |
| US07/889,017 | 1992-05-26 | ||
| US89593092A | 1992-06-09 | 1992-06-09 | |
| US07/895,930 | 1992-06-09 | ||
| US98851892A | 1992-12-10 | 1992-12-10 | |
| US07/988,518 | 1992-12-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2118522A1 true CA2118522A1 (fr) | 1993-12-09 |
Family
ID=27420535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002118522A Abandoned CA2118522A1 (fr) | 1992-05-26 | 1993-05-24 | Administration au moment opportun de glycosides oligosaccharidiques associes a des determinants du groupe sanguin et ayant une structure centrale de type i ou ii afin de reduire l'inflammation chez un mammifere sensibilise par suite de l'exposition a un antigene |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0650492A1 (fr) |
| JP (1) | JPH07507312A (fr) |
| CA (1) | CA2118522A1 (fr) |
| WO (1) | WO1993024505A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2157489A1 (fr) * | 1993-03-04 | 1994-09-15 | Masaaki Numata | Compose associe de type lewis, procede pour sa production et anti-inflammatoire utilisant ce produit |
| US5514665A (en) * | 1993-12-30 | 1996-05-07 | University Of British Columbia | Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans |
| WO1998014458A1 (fr) * | 1996-10-02 | 1998-04-09 | Glycorex Ab | Inhibiteurs d'adherence cellulaire antiinflammatoires |
| US6110897A (en) * | 1996-10-10 | 2000-08-29 | Glycorex Ab | Antiinflammatory cell adhesion inhibitors |
| GB9710351D0 (en) * | 1997-05-20 | 1997-07-16 | Scotia Holdings Plc | Glucosamine fatty acids |
| AU752880B2 (en) * | 1998-07-27 | 2002-10-03 | E-L Management Corporation | Topical compositions containing sialyl sugars and their derivatives |
| GB0716968D0 (en) * | 2007-08-31 | 2007-10-10 | Vivacta Ltd | Sensor |
| WO2013190531A1 (fr) * | 2012-06-22 | 2013-12-27 | Glycom A/S | Galactosyl disaccharides glycosylés, leurs procédés de production et leur utilisation dans des produits consommables |
| WO2013190529A1 (fr) * | 2012-06-22 | 2013-12-27 | Glycom A/S | Disaccharides galactosyliques glycolysés, procédés de préparation et leur utilisation dans des produits consommables |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1544908A (en) * | 1975-07-08 | 1979-04-25 | Chembiomed Ltd | Artificial oligosaccharide antigenic determinants |
| GB1603609A (en) * | 1977-04-14 | 1981-11-25 | Chembiomed Ltd | O-protected 2-azido-2-deoxy-glycosyl nitrates |
| US4767845A (en) * | 1980-07-10 | 1988-08-30 | Chembiomed, Ltd. | Synthesis of tumor antigenic determinant |
| SE8203925D0 (sv) * | 1982-06-23 | 1982-06-23 | Svenska Sockerfabriks Ab | New and novel glycosides, glycoconjugates and processes for their preparation |
-
1993
- 1993-05-24 CA CA002118522A patent/CA2118522A1/fr not_active Abandoned
- 1993-05-24 JP JP6500690A patent/JPH07507312A/ja active Pending
- 1993-05-24 WO PCT/US1993/004909 patent/WO1993024505A1/fr not_active Ceased
- 1993-05-24 EP EP93914105A patent/EP0650492A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993024505A1 (fr) | 1993-12-09 |
| EP0650492A1 (fr) | 1995-05-03 |
| JPH07507312A (ja) | 1995-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5646123A (en) | Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen | |
| US5580858A (en) | Immunosuppressive and tolerogenic modified Lewisx compounds | |
| US5550155A (en) | Methods for the synthesis of monofucosylated oligosaccharides terminating in di-N-acetyllactosaminyl structures | |
| EP0589933B1 (fr) | Methodes de synthese enzymatique de glycosides d'oligosaccharides a sialylation alpha | |
| JP2590248B2 (ja) | 抗ウイルス・抗腫瘍・抗転移・免疫系増強ヌクレオシド類およびヌクレオチド類 | |
| US5939290A (en) | Modified sialyl Lewisx compounds | |
| Abronina et al. | The use of silyl groups in the synthesis of arabinofuranosides | |
| US5872096A (en) | Modified sialyl Lewisa compounds | |
| CA2118522A1 (fr) | Administration au moment opportun de glycosides oligosaccharidiques associes a des determinants du groupe sanguin et ayant une structure centrale de type i ou ii afin de reduire l'inflammation chez un mammifere sensibilise par suite de l'exposition a un antigene | |
| EP0588852A1 (fr) | Derives d'oligosaccharide immunosuppresseurs et tolerogenes | |
| JP2823358B2 (ja) | 免疫抑制性および寛容原性修飾ルイス▲上c▼およびLacNAc化合物 | |
| EP0591254A1 (fr) | Composes modifies immunosuppresseurs et tolerogenes de lewis?x et de lewis?a | |
| EP0830365B1 (fr) | Analogues kojibiosides modifies | |
| WO1996016071A1 (fr) | PROCEDES POUR SYNTHETISER DE COMPOSES DE LEWISx SUBSTITUES EN 3' | |
| Cato | Chemical synthesis of the O-linked oligosaccharide of P-Selectin Glycoprotein Ligand-1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |